SinghMK,KikiD,Chang, 2012.The neural effects of psychotropic medications in children and adolescents,Child Adolesc Psychiatr Clin N Am 21 753 -71
StallerJA,WadeMJ,BakerM., 2005.Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York,J Child Adolesc Psychopharmacol 15 57 -61
BjorkenstamE,HjernA,Mittendorfer-RutzE,VinnerlijungB,HallqvistJ,Ljung R. Multi, 2013.- exposure and culturing of adverse childhood expericnes, socioeconomic differences and psycotropic medication in young adults,PLoS One 8 e53551 -
GarbeldDL,BrownDS,AllairB,RossRE,NicolG,RaghavanR, 2015.Psycotropic drug use among preschool children in the mecaid from 36 states,Am J Public Health 105 524 -29
ChirdkiatyumchiaV,XiaoH,FredstromBk,AdamsRE,EpsteinJN,ShahSS, 2013.National trends in psycotropic medication use in young children: 1994-2009,Pediatrics 132 615 -23
HarrisonJN,Cluxton-KellerF,GrossMAD, 2012.Antipsychotic medication prescribing trends in children and adolescents,J Pediatr Health Care 26 139 -45
SpencerD,MarshalJ,PostB,KulakodluM,News ChafferC,DennenT, 2013.Psychotropic medication use and poly pharmacy is children with autism spectrum disorders,Pediatrics 132 833 -40
BottelierMA,SchouwMLJ,KlompA,TammingaHGT,SchranteeAGM,BouzianeC, 2014.The effects of psycotropic drugs on developing brain (e POD) Study: Methods and Designs,BMC Psychiatry 48 1 -12
ZitoJM,BurcuM,IbeA,SaferDJ,MagderLS, 2013.Antipsychotic use by medicaid-insured youths: Impact of eligibility and psychiatric diagnosis across a decase,Psychiatr Serv 64 223 -29
BoboWV,CooperWO,SteinCM, 2013.Antipsychotics and the risk of type 2 diabetes melitus in children and youth,JAMA Psychiatry 70 1067 -75